Advancing Medical Science

Pioneering Breakthroughs in Clinical Research

A comprehensive portfolio of Phase I-IV trials, observational studies, and data-driven insights accelerating the journey from concept to cure.

0
Years Experience
0+
Studies Conducted
0
Therapeutic Areas
0%
Data Accuracy

About Nexus

Dedicated to Scientific Excellence and Patient Safety

We are a premier clinical research organization partnering with leading pharmaceutical, biotechnology, and medical device companies to bring innovative therapies to market.

Rigorous Methodology

Our strict adherence to ICH-GCP guidelines ensures the highest quality of clinical data, maintaining trial integrity from initiation to closeout.

Patient-Centric Approach

We prioritize patient safety, comfort, and engagement, resulting in industry-leading retention rates and diverse participant enrollment.

Advanced Infrastructure

Utilizing state-of-the-art EDC systems and digital health technologies to streamline operations and provide real-time data access.

Our Portfolio

Featured Research Projects

A curated selection of our recent clinical trials and observational studies across various therapeutic areas.

Phase III
Oncology / Pulmonology

Targeted Therapy for NSCLC

A randomized, double-blind study evaluating the efficacy and safety of a novel kinase inhibitor in patients with advanced Non-Small Cell Lung Cancer.

450 Participants
View Details
Phase IIa
Neurology

Alzheimer's Early Intervention

Evaluating the tolerability and biomarker response of monoclonal antibodies in patients with early-stage Alzheimer's disease.

120 Participants
View Details
Observational
Cardiology

Longitudinal Heart Failure Registry

A multi-center registry collecting real-world data to assess long-term cardiovascular outcomes and quality of life in chronic heart failure patients.

2,500+ Participants
View Details
Phase I/II
Infectious Disease

Novel Antiviral Efficacy

Dose-escalation study assessing the safety, pharmacokinetics, and preliminary efficacy of a broad-spectrum oral antiviral agent.

60 Participants
View Details

View Full Portfolio

Access our complete database of past and ongoing research studies.

Our Capabilities

End-to-End Clinical Trial Services

Study Feasibility & Site Selection

Rapid assessment of protocol viability utilizing our extensive network of principal investigators and historical performance metrics.

Patient Recruitment & Retention

Targeted outreach strategies and patient-centric clinic environments designed to meet enrollment goals and minimize dropout rates.

Clinical Data Management

Secure, 21 CFR Part 11 compliant data capture and processing ensuring high-quality, audit-ready datasets for regulatory submission.

Regulatory Compliance (QA/QC)

Dedicated quality assurance team overseeing SOP adherence, conducting internal audits, and facilitating sponsor/IRB communications.

Discuss Your Next Study

Partner with Nexus Clinical Research for reliable data, swift timelines, and uncompromising quality.

Headquarters

123 Science Park Drive, Research Triangle, NC

Phone

+1 (800) 555-0198

Email

partnerships@nexusresearch.com